Cargando…
The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group
The advent of immune-checkpoint inhibitors (ICI) in modern oncology has significantly improved survival in several cancer settings. A subgroup of women with breast cancer (BC) has immunogenic infiltration of lymphocytes with expression of programmed death-ligand 1 (PD-L1). These patients may potenti...
Ejemplares similares
-
Starvation tactics using natural compounds for advanced cancers: pharmacodynamics, clinical efficacy, and predictive biomarkers
por: El Bairi, Khalid, et al.
Publicado: (2018) -
Ovarian cancer in Morocco: Time to act is now
por: El Bairi, Khalid, et al.
Publicado: (2021) -
Tracing ovarian cancer research in Morocco: A bibliometric analysis
por: El Bairi, Khalid, et al.
Publicado: (2021) -
Inexpensive Systemic Inflammatory Biomarkers in Ovarian Cancer: An Umbrella Systematic Review of 17 Prognostic Meta-Analyses
por: El Bairi, Khalid, et al.
Publicado: (2021) -
Practical Tools and Guidelines for Young Oncologists From Resource-Limited Settings to Publish Excellence and Advance Their Career
por: El Bairi, Khalid, et al.
Publicado: (2021)